OPPENHEIMER & CO INC - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 25 filers reported holding BIOPHARMX CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2019$3,0000.0%35,000
+40.0%
0.00%
Q4 2018$3,000
-70.0%
25,000
-54.5%
0.00%
Q3 2018$10,000
+25.0%
55,000
+57.1%
0.00%
Q2 2018$8,000
+14.3%
35,000
+12.9%
0.00%
Q1 2018$7,000
+250.0%
31,000
+47.6%
0.00%
Q4 2017$2,000
-77.8%
21,000
-36.4%
0.00%
Q3 2017$9,000
-30.8%
33,000
+17.9%
0.00%
Q2 2017$13,00028,0000.00%
Other shareholders
BIOPHARMX CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 16,128,515$1,740,0000.22%
FRG Family Wealth Advisors LLC 30,000$3,0000.00%
LEVEL FOUR ADVISORY SERVICES, LLC 66,933$7,0000.00%
Chicago Partners Investment Group LLC 32,462$4,0000.00%
Virtu Financial LLC 98,004$11,0000.00%
NORTHERN TRUST CORP 92,518$10,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 1,343,372$144,0000.00%
MILLENNIUM MANAGEMENT LLC 25,349$3,0000.00%
OPPENHEIMER & CO INC 25,000$3,0000.00%
View complete list of BIOPHARMX CORP shareholders